{
    "2018-04-27": [
        [
            {
                "time": "2018-04-15",
                "original_text": "Lilly to Participate in Bank of America Merrill Lynch Health Care Conference",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Bank of America",
                        "Merrill Lynch",
                        "Health Care Conference"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "How Did BioMarin Pharmaceutical Perform in 1Q18?",
                "features": {
                    "keywords": [
                        "BioMarin",
                        "Pharmaceutical",
                        "1Q18"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-25",
                "original_text": "Eli Lilly’s 1Q18 Earnings: Human Pharmaceutical Products Segment",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "1Q18",
                        "Earnings",
                        "Human Pharmaceutical Products"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-26",
                "original_text": "Eli Lilly’s 1Q18 Earnings by Segment",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "1Q18",
                        "Earnings",
                        "Segment"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-30",
                "original_text": "Allergan’s 1Q18 Estimates: Expect Growth in Revenues",
                "features": {
                    "keywords": [
                        "Allergan",
                        "1Q18",
                        "Estimates",
                        "Growth",
                        "Revenues"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-01",
                "original_text": "Eli Lilly’s 1Q18 Earnings and Revenue Growth",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "1Q18",
                        "Earnings",
                        "Revenue Growth"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-05",
                "original_text": "Analyst Recommendations for Novo Nordisk in April",
                "features": {
                    "keywords": [
                        "Analyst",
                        "Recommendations",
                        "Novo Nordisk",
                        "April"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "How Is Novo Nordisk Positioned before 1Q18?",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "1Q18",
                        "Positioned"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}